Revolade 25 mg 28 Tablet

Revolade 25 mg 28 Tablet revolade SmPC updated with details of new paediatric indication: “Revolade is indicated for chronic immune thrombocytopenic purpura patients aged 1 revolade INDICATIONS • REVOLADE tablets are indicated for the treatment of chronic immune thrombocytopenia to increase platelet

revolade Revolade 25mg Tablet Revolade 25mg Tablet is used to treat low platelet count due to chronic immune thrombocytopenic purpura

revolade Revolade pCPA File Number: 20760 Negotiation Status: Negotiations were not pursued Indication: Thrombocytopenia associated Revolade 50 mg Tablet is used to treat low blood platelet count in patients with idiopathic thrombocytopenic purpura and hepatitis C virus